Page 9 - பல்கலைக்கழகம் ஆஃப் க்ரீஃப்ஸ்‌வால்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Todo lo que hay que saber sobre la vacuna de Janssen

Todo lo que hay que saber sobre la vacuna de Janssen
elnortedecastilla.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elnortedecastilla.es Daily Mail and Mail on Sunday newspapers.

Castilla la manachaUnited statesUnited kingdomAndreas greinacherUniversity of greifswaldCommittee of medicinesAgency medicine spaniardResearch margaretheInstitute of scientific research university hospitalJanssen theJanssen roadBelga janssenDeep veinThe united statesMedicines forScientific research university hospital

The Blood-Clot Problem Is Multiplying

The Blood-Clot Problem Is Multiplying Roxanne Khamsi © Provided by The Atlantic DeAgostini / Getty / Katie Martin / The Atlantic For weeks, Americans looked on as other countries grappled with case reports of rare, sometimes fatal blood abnormalities among those who had received the AstraZeneca vaccine against COVID-19. That vaccine has not yet been authorized by the FDA, so restrictions on its use throughout Europe did not get that much attention in the United States. But Americans experienced a rude awakening this week when public-health officials called for a pause on the use of the Johnson & Johnson vaccine, after a few cases of the same, unusual blood-clotting syndrome turned up among the millions of people in the country who have received it.

United statesMarshfield clinicMecklenburg vorpommernBruxelles capitaleSaskia middeldorpDeagostini getty katie martinSabine eichingerDavid leeDavid kaslowKai kupferschmidtAndreas greinacherMichel goldmanEd belongiaGretchen vogelPopulation health at marshfield clinic research instituteFree university of brussels

Vaccine link to serious clotting disorder firms up

Vaccine link to serious clotting disorder firms up
sciencemag.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemag.org Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMecklenburg vorpommernPeter marksRolf marschalekGowthami arepallyPeter hotezAtlantic oceanAndreas greinacherCansino biologicsHeising simons foundationCenters for diseaseDuke university school of medicineDrug administrationFrankfurt universityUniversity of greifswald

COVID: Is there a link between vector vaccines and thrombosis? | Science| In-depth reporting on science and technology | DW

COVID: Is there a link between vector vaccines and thrombosis? First, cerebral venous sinus thrombosis occurred with the vaccine from AstraZeneca, now similar cases have shown up with the Johnson & Johnson vaccine. Does this have anything to do with the way vector vaccines work? Two vector vaccines are suspected of increasing the risk of thrombosis Following the occurrence of cerebral venous sinus thromboses in mostly younger people who had received the AstraZeneca vaccine in recent months, something similar now appears to be happening with the Johnson & Johnson vaccine. Vaccinations with the active ingredient have been temporarily suspended in the US.

United kingdomBaden wübergMecklenburg vorpommernBerlin friedrichshainNordrhein westfalenSerbien grippewelleJohannes oldenburgAndreas greinacherChristian bogdanRobert klamrothSchlafen symbolbildGerman permanent vaccination commission stikoGerman press agencyBonn university hospitalUniversity of greifswaldMicrobiological institute of the university hospital erlangen

Vaccine link to serious clotting disorder firms up

People line up to receive AstraZeneca s COVID-19 vaccine in Belfast, Northern Ireland. PHOTO: CLODAGH KILCOYNE/REUTERS A rare but very serious side effect that has complicated Europe s COVID-19 vaccination schedules for the past month has now thrown a wrench into U.S. immunization efforts as well. Researchers believe the problem, characterized by dangerous blood clots and low platelet counts, may be triggered by vaccines produced by AstraZeneca and Johnson & Johnson (J&J), which both contain a modified adenovirus. They have identified an errant immune reaction as the possible cause, but don t yet understand how it arises. There are 222 suspected cases of the syndrome so far in Europe among 34 million people who have received their first dose of the AstraZeneca vaccine, recently named Vaxzevria; more than 30 have died. The European Medicines Agency (EMA) on 7 April acknowledged “a probable causal association” between the syndrome and the vaccine, and some countries have restric

United statesUnited kingdomMecklenburg vorpommernPeter marksRolf marschalekGowthami arepallyPeter hotezAtlantic oceanAndreas greinacherCansino biologicsHeising simons foundationCenters for diseaseDuke university school of medicineDrug administrationFrankfurt universityUniversity of greifswald